Market Cap 68.96M
Revenue (ttm) 0.00
Net Income (ttm) -77.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 704,200
Avg Vol 454,880
Day's Range N/A - N/A
Shares Out 53.46M
Stochastic %K 59%
Beta 1.37
Analysts Strong Sell
Price Target $4.20

Company Profile

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorpora...

Industry: Biotechnology
Sector: Healthcare
Phone: 609 642 6670
Address:
400 Alexander Park Drive, Suite 301, Princeton, United States
topstockalerts
topstockalerts Sep. 2 at 12:05 AM
$PMVP where do you think this goes from here?
1 · Reply
TooMuchFinesse
TooMuchFinesse Sep. 1 at 8:26 PM
$PMVP letting it run so they can exercise warrants. Then short it back down and protect the support over $1. I see the game they’re playing. Load the dips only.
0 · Reply
algo888
algo888 Sep. 1 at 7:50 PM
$PMVP 1.30 Last Chance
0 · Reply
Nost
Nost Sep. 1 at 5:16 PM
$PMVP If this pumper shows up, you know its time to sell..
0 · Reply
algo888
algo888 Sep. 1 at 4:36 PM
$PMVP Huge Block Buys incoming... Load it Fools
0 · Reply
algo888
algo888 Sep. 1 at 4:27 PM
$PMVP ASK super thin to 1.80 - 2.00 range
0 · Reply
algo888
algo888 Sep. 1 at 4:23 PM
$PMVP https://www.tipranks.com/news/blurbs/craig-hallum-sticks-to-their-buy-rating-for-pmv-pharmaceuticals-pmvp-blurbs-news?mod=mw_quote_news
0 · Reply
algo888
algo888 Sep. 1 at 4:15 PM
0 · Reply
algo888
algo888 Sep. 1 at 4:08 PM
$PMVP Avg Daily vol: 310,000 Volume now just crossed 5 million Push it....
0 · Reply
algo888
algo888 Sep. 1 at 4:05 PM
$PMVP Trigger it above 1.37 Baby BOOOOOOOOMAGE imminent !!!!! $$$$$$
0 · Reply
Latest News on PMVP
PMV Pharmaceuticals 42M share Spot Secondary priced at $1.21

2026-09-01T03:20:07.000Z - 2 days ago

PMV Pharmaceuticals 42M share Spot Secondary priced at $1.21


PMV Pharma Announces Proposed Public Offering of Securities

Aug 31, 2026, 4:02 PM EDT - 2 days ago

PMV Pharma Announces Proposed Public Offering of Securities


PMV Pharmaceuticals reports Q2 EPS (34c), consensus (40c)

2026-08-16T13:28:15.000Z - 17 days ago

PMV Pharmaceuticals reports Q2 EPS (34c), consensus (40c)


PMV Pharmaceuticals Quarterly report: Q2 2026

Aug 14, 2026, 7:00 AM EDT - 19 days ago

PMV Pharmaceuticals Quarterly report: Q2 2026


PMV Pharmaceuticals Earnings release: Q2 2026

Aug 14, 2026, 7:00 AM EDT - 19 days ago

PMV Pharmaceuticals Earnings release: Q2 2026


PMV Pharmaceuticals assumed with a Buy at Ladenburg

2026-07-08T11:46:15.000Z - 1 month ago

PMV Pharmaceuticals assumed with a Buy at Ladenburg


PMV Pharmaceuticals Transcript: AGM 2026

Jun 4, 2026, 10:00 AM EDT - 3 months ago

PMV Pharmaceuticals Transcript: AGM 2026


PMV Pharmaceuticals reports Q1 EPS (34c), consensus (38c)

2026-05-12T16:19:03.000Z - 3 months ago

PMV Pharmaceuticals reports Q1 EPS (34c), consensus (38c)


PMV Pharmaceuticals Quarterly report: Q1 2026

May 12, 2026, 8:00 AM EDT - 3 months ago

PMV Pharmaceuticals Quarterly report: Q1 2026


PMV Pharmaceuticals Earnings release: Q1 2026

May 12, 2026, 8:00 AM EDT - 3 months ago

PMV Pharmaceuticals Earnings release: Q1 2026


PMV Pharmaceuticals Announces Board Chair Transition

Apr 22, 2026, 8:00 AM EDT - 4 months ago

PMV Pharmaceuticals Announces Board Chair Transition


PMV Pharmaceuticals Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 4 months ago

PMV Pharmaceuticals Proxy statement: Proxy filing


PMV Pharmaceuticals Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 4 months ago

PMV Pharmaceuticals Proxy statement: Proxy filing


PMV Pharmaceuticals reports FY25 EPS ($1.48), consensus ($1.51)

2026-03-06T13:13:11.000Z - 6 months ago

PMV Pharmaceuticals reports FY25 EPS ($1.48), consensus ($1.51)


PMV Pharmaceuticals sees cash runway to end of 2Q27

2026-03-06T13:12:36.000Z - 6 months ago

PMV Pharmaceuticals sees cash runway to end of 2Q27


PMV Pharmaceuticals Earnings release: Q4 2025

Mar 6, 2026, 7:00 AM EST - 6 months ago

PMV Pharmaceuticals Earnings release: Q4 2025


PMV Pharmaceuticals Annual report: Q4 2025

Mar 6, 2026, 7:00 AM EST - 6 months ago

PMV Pharmaceuticals Annual report: Q4 2025


PMV Pharmaceuticals Slides: Corporate presentation

Feb 5, 2026, 7:00 AM EST - 6 months ago

PMV Pharmaceuticals Slides: Corporate presentation


PMV Pharmaceuticals reports Q3 EPS (40c), consensus (40c)

2025-11-12T13:11:52.000Z - 9 months ago

PMV Pharmaceuticals reports Q3 EPS (40c), consensus (40c)


PMV Pharmaceuticals Earnings release: Q3 2025

Nov 12, 2025, 8:00 AM EST - 9 months ago

PMV Pharmaceuticals Earnings release: Q3 2025


PMV Pharmaceuticals Quarterly report: Q3 2025

Nov 12, 2025, 8:00 AM EST - 9 months ago

PMV Pharmaceuticals Quarterly report: Q3 2025


PMV Pharmaceuticals reports Q2 EPS (41c), consensus (38c)

2025-08-07T12:45:49.000Z - 1 year ago

PMV Pharmaceuticals reports Q2 EPS (41c), consensus (38c)


PMV Pharmaceuticals Quarterly report: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

PMV Pharmaceuticals Quarterly report: Q2 2025


PMV Pharmaceuticals Earnings release: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

PMV Pharmaceuticals Earnings release: Q2 2025


PMV Pharmaceuticals reports Q1 EPS (34c), consensus (38c)

2025-05-09T12:12:55.000Z - 1 year ago

PMV Pharmaceuticals reports Q1 EPS (34c), consensus (38c)


PMV Pharmaceuticals sees cash runway to end of 2026

2025-05-09T12:12:28.000Z - 1 year ago

PMV Pharmaceuticals sees cash runway to end of 2026


PMV Pharmaceuticals Quarterly report: Q1 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

PMV Pharmaceuticals Quarterly report: Q1 2025


PMV Pharmaceuticals Earnings release: Q1 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

PMV Pharmaceuticals Earnings release: Q1 2025


PMV Pharmaceuticals Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

PMV Pharmaceuticals Proxy statement: Proxy Filing


PMV Pharmaceuticals Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

PMV Pharmaceuticals Proxy statement: Proxy Filing


PMV Pharmaceuticals sees cash runway to end of 2026

2025-03-03T13:11:53.000Z - 1 year ago

PMV Pharmaceuticals sees cash runway to end of 2026


PMV Pharmaceuticals Annual report: Q4 2024

Mar 3, 2025, 8:00 AM EST - 1 year ago

PMV Pharmaceuticals Annual report: Q4 2024


PMV Pharmaceuticals Earnings release: Q4 2024

Mar 3, 2025, 8:00 AM EST - 1 year ago

PMV Pharmaceuticals Earnings release: Q4 2024


PMV Pharmaceuticals Slides: Corporate Presentation

Feb 12, 2025, 3:18 PM EST - 1 year ago

PMV Pharmaceuticals Slides: Corporate Presentation


PMV Pharmaceuticals Quarterly report: Q3 2024

Nov 7, 2024, 7:00 AM EST - 1 year ago

PMV Pharmaceuticals Quarterly report: Q3 2024


PMV Pharmaceuticals Earnings release: Q3 2024

Nov 7, 2024, 7:00 AM EST - 1 year ago

PMV Pharmaceuticals Earnings release: Q3 2024


PMV Pharmaceuticals Quarterly report: Q2 2024

Aug 8, 2024, 7:00 AM EDT - 2 years ago

PMV Pharmaceuticals Quarterly report: Q2 2024


PMV Pharmaceuticals Earnings release: Q2 2024

Aug 8, 2024, 7:00 AM EDT - 2 years ago

PMV Pharmaceuticals Earnings release: Q2 2024


PMV Pharmaceuticals Quarterly report: Q1 2024

May 9, 2024, 7:00 AM EDT - 2 years ago

PMV Pharmaceuticals Quarterly report: Q1 2024


PMV Pharmaceuticals Earnings release: Q1 2024

May 9, 2024, 7:00 AM EDT - 2 years ago

PMV Pharmaceuticals Earnings release: Q1 2024


PMV Pharmaceuticals Proxy statement: Proxy Filing

Apr 24, 2024, 8:00 AM EDT - 2 years ago

PMV Pharmaceuticals Proxy statement: Proxy Filing


PMV Pharmaceuticals Proxy statement: Proxy Filing

Apr 24, 2024, 8:00 AM EDT - 2 years ago

PMV Pharmaceuticals Proxy statement: Proxy Filing


PMV Pharmaceuticals Press release: FY 2024

Mar 18, 2024, 8:00 AM EDT - 2 years ago

PMV Pharmaceuticals Press release: FY 2024


PMV Pharmaceuticals Slides: FY 2024

Mar 18, 2024, 8:00 AM EDT - 2 years ago

PMV Pharmaceuticals Slides: FY 2024


PMV Pharmaceuticals Annual report: Q4 2023

Feb 29, 2024, 7:00 AM EST - 2 years ago

PMV Pharmaceuticals Annual report: Q4 2023


PMV Pharmaceuticals Earnings release: Q4 2023

Feb 29, 2024, 7:00 AM EST - 2 years ago

PMV Pharmaceuticals Earnings release: Q4 2023


PMV Pharmaceuticals Quarterly report: Q3 2023

Nov 9, 2023, 7:00 AM EST - 2 years ago

PMV Pharmaceuticals Quarterly report: Q3 2023


PMV Pharmaceuticals Earnings release: Q3 2023

Nov 9, 2023, 7:00 AM EST - 2 years ago

PMV Pharmaceuticals Earnings release: Q3 2023


PMV Pharmaceuticals Slides: KOL Presentation

Oct 12, 2023, 7:00 AM EDT - 2 years ago

PMV Pharmaceuticals Slides: KOL Presentation


PMV Pharmaceuticals Slides: Study Update

Oct 11, 2023, 7:00 AM EDT - 2 years ago

PMV Pharmaceuticals Slides: Study Update


PMV Pharmaceuticals Quarterly report: Q2 2023

Aug 9, 2023, 7:00 AM EDT - 3 years ago

PMV Pharmaceuticals Quarterly report: Q2 2023


PMV Pharmaceuticals Earnings release: Q2 2023

Aug 9, 2023, 7:00 AM EDT - 3 years ago

PMV Pharmaceuticals Earnings release: Q2 2023


PMV Pharmaceuticals Quarterly report: Q1 2023

May 10, 2023, 7:00 AM EDT - 3 years ago

PMV Pharmaceuticals Quarterly report: Q1 2023


PMV Pharmaceuticals Earnings release: Q1 2023

May 10, 2023, 7:00 AM EDT - 3 years ago

PMV Pharmaceuticals Earnings release: Q1 2023


PMV Pharmaceuticals Proxy statement: Proxy Filing

Apr 28, 2023, 8:00 AM EDT - 3 years ago

PMV Pharmaceuticals Proxy statement: Proxy Filing


PMV Pharmaceuticals Proxy statement: Proxy Filing

Apr 28, 2023, 8:00 AM EDT - 3 years ago

PMV Pharmaceuticals Proxy statement: Proxy Filing


PMV Pharmaceuticals Annual report: Q4 2022

Mar 1, 2023, 7:00 AM EST - 3 years ago

PMV Pharmaceuticals Annual report: Q4 2022


PMV Pharmaceuticals Earnings release: Q4 2022

Mar 1, 2023, 7:00 AM EST - 3 years ago

PMV Pharmaceuticals Earnings release: Q4 2022


PMV Pharmaceuticals Earnings release: Q3 2022

Nov 8, 2022, 7:00 AM EST - 3 years ago

PMV Pharmaceuticals Earnings release: Q3 2022


PMV Pharmaceuticals Quarterly report: Q3 2022

Nov 8, 2022, 7:00 AM EST - 3 years ago

PMV Pharmaceuticals Quarterly report: Q3 2022


PMV Pharmaceuticals Press release: Q3 2022

Nov 8, 2022, 7:00 AM EST - 3 years ago

PMV Pharmaceuticals Press release: Q3 2022


PMV Pharmaceuticals Quarterly report: Q2 2022

Aug 9, 2022, 7:00 AM EDT - 4 years ago

PMV Pharmaceuticals Quarterly report: Q2 2022


PMV Pharmaceuticals Earnings release: Q2 2022

Aug 9, 2022, 7:00 AM EDT - 4 years ago

PMV Pharmaceuticals Earnings release: Q2 2022


PMV Pharmaceuticals Quarterly report: Q1 2022

May 10, 2022, 7:00 AM EDT - 4 years ago

PMV Pharmaceuticals Quarterly report: Q1 2022


PMV Pharmaceuticals Earnings release: Q1 2022

May 10, 2022, 7:00 AM EDT - 4 years ago

PMV Pharmaceuticals Earnings release: Q1 2022


PMV Pharmaceuticals Proxy statement: Proxy Filing

Apr 22, 2022, 8:00 AM EDT - 4 years ago

PMV Pharmaceuticals Proxy statement: Proxy Filing


PMV Pharmaceuticals Proxy statement: Proxy Filing

Apr 22, 2022, 8:00 AM EDT - 4 years ago

PMV Pharmaceuticals Proxy statement: Proxy Filing


PMV Pharma Announces Changes to its Board of Directors

Jan 6, 2022, 8:00 AM EST - 4 years ago

PMV Pharma Announces Changes to its Board of Directors


PMV Pharmaceuticals Proxy statement: Proxy Filing

Apr 23, 2021, 8:00 AM EDT - 5 years ago

PMV Pharmaceuticals Proxy statement: Proxy Filing


PMV Pharmaceuticals Proxy statement: Proxy Filing

Apr 23, 2021, 8:00 AM EDT - 5 years ago

PMV Pharmaceuticals Proxy statement: Proxy Filing


topstockalerts
topstockalerts Sep. 2 at 12:05 AM
$PMVP where do you think this goes from here?
1 · Reply
TooMuchFinesse
TooMuchFinesse Sep. 1 at 8:26 PM
$PMVP letting it run so they can exercise warrants. Then short it back down and protect the support over $1. I see the game they’re playing. Load the dips only.
0 · Reply
algo888
algo888 Sep. 1 at 7:50 PM
$PMVP 1.30 Last Chance
0 · Reply
Nost
Nost Sep. 1 at 5:16 PM
$PMVP If this pumper shows up, you know its time to sell..
0 · Reply
algo888
algo888 Sep. 1 at 4:36 PM
$PMVP Huge Block Buys incoming... Load it Fools
0 · Reply
algo888
algo888 Sep. 1 at 4:27 PM
$PMVP ASK super thin to 1.80 - 2.00 range
0 · Reply
algo888
algo888 Sep. 1 at 4:23 PM
$PMVP https://www.tipranks.com/news/blurbs/craig-hallum-sticks-to-their-buy-rating-for-pmv-pharmaceuticals-pmvp-blurbs-news?mod=mw_quote_news
0 · Reply
algo888
algo888 Sep. 1 at 4:15 PM
0 · Reply
algo888
algo888 Sep. 1 at 4:08 PM
$PMVP Avg Daily vol: 310,000 Volume now just crossed 5 million Push it....
0 · Reply
algo888
algo888 Sep. 1 at 4:05 PM
$PMVP Trigger it above 1.37 Baby BOOOOOOOOMAGE imminent !!!!! $$$$$$
0 · Reply
algo888
algo888 Sep. 1 at 3:58 PM
$PMVP Load all you can quietly..
0 · Reply
algo888
algo888 Sep. 1 at 3:56 PM
$PMVP In @ 1.27 50 million share repurchase
0 · Reply
FlashMcGash
FlashMcGash Sep. 1 at 3:26 PM
$PMVP something hapoening here....the Updated Rezatapopt Ovarian Cancer Data appears to be significant enough to ignore the offering.
3 · Reply
Invescent
Invescent Sep. 1 at 2:59 PM
$AUUD $PMVP Both were picked up early by our volume scanner today. AUUD was detected around $0.986 after 5-minute volume jumped 3.13x from the previous candle. It has since pushed above $1.00 and tested $1.015. PMVP was detected around $1.176 after 5-minute volume jumped 2.30x from the previous candle. It has since moved toward $1.20. Watching both for continued volume and momentum.
0 · Reply
LittleBobbyAxelrod
LittleBobbyAxelrod Sep. 1 at 1:34 PM
$PMVP Green?
0 · Reply
TooMuchFinesse
TooMuchFinesse Sep. 1 at 9:28 AM
$PMVP okay , I read the offering news. & I have my plan. Still on the sidelines
0 · Reply
TooMuchFinesse
TooMuchFinesse Sep. 1 at 9:11 AM
$PMVP Yes ! Fall! I love overreactions! 🚛🚛🚛🚛🚛
0 · Reply
investfreakycat
investfreakycat Sep. 1 at 4:29 AM
$PMVP announced today the pricing of an underwritten public offering consisting of (i) 22,055,000 shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase an aggregate of up to 19,900,000 shares of its common stock, and (ii) accompanying warrants to purchase an aggregate of 41,955,000 shares of common stock. The common stock and pre-funded warrants are being sold in combination with an accompanying warrant to purchase one share of common stock for each share of common stock or pre-funded warrant sold. The accompanying warrants have an initial exercise price of $1.21 per share, subject to adjustment following a specified regulatory milestone, are immediately exercisable from the date of issuance and will expire five years from the date of issuance. The combined public offering price of each share of common stock and accompanying warrant is $1.21.
1 · Reply
justiceforb_85
justiceforb_85 Sep. 1 at 1:01 AM
$PMVP data update for rezatapopt very reassuring. They have a drug they can get to approval. Offering is meh but likely a good opportunity to add given the current cash position of company.
2 · Reply
Biotech_Pharma_Investor
Biotech_Pharma_Investor Sep. 1 at 12:48 AM
$PMVP "In addition, beginning on the date of the NDA Acceptance Announcement, the exercise price of the common stock warrants will be reduced to the Reset Exercise Price if such Reset Exercise Price is less than the initial exercise price."...
0 · Reply
LittleBobbyAxelrod
LittleBobbyAxelrod Aug. 31 at 9:54 PM
$PMVP Results look consistent may add on another dip here.
1 · Reply
Doom_Gloom_AR
Doom_Gloom_AR Aug. 31 at 9:00 PM
$PMVP made a first buy here at $1.05 - seems cheap for what they got, should be valued in the 300-600m cap range, evenwith the offering 2x the share price it's worth at least $2.5 a share
0 · Reply